C-Cog in Early Course Schizophrenia Study

Stopped early · Phase 4

Conditions studied: Schizophrenia

In brief

The purpose of this study is to examine the role of clinical stability in functional recovery. in first episode schizophrenia.

Key facts

Study ID

NCT05662306

Run by

University of Miami

People needed

1

Starts

2024-01-23

Expected to finish

2025-03-03

Last updated by the study team

2026-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults
• Diagnosis of schizophrenia
• Current Hospitalization or outpatient relapse
• Fewer than four previous admissions
• Willing to accept long-acting injectable treatment and participate in rehabilitation

You may not qualify if…

• Primary diagnosis other than schizophrenia
• Prior Long Acting Injectable treatment
• Current Suicide Risk
• Hypersensitivity to Aripiprazole
• Pregnancy
• Positive illicit drug screen other than cannabis (rescreening allowed in 4 weeks for drug positive cases)
• Unable to give personal informed consent
• History of treatment resistance as evidenced by clozapine treatment
• Unable to stop treatment with medications that are strong Cytochrome (CYP) 2D6 or CYP 3A4 inhibitors and or strong CYP3A4 inducers (2.3, 7.1) for at 14 days prior to initiation.

Where it is running

• Jackson Memorial Hospital — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.